Multicenter evaluation of emergency department treatment for children and adolescents with Crohn's disease according to race/ethnicity and insurance payor status by Dotson, J.L. et al.
Multicenter Evaluation of Emergency Department Treatment for 
Children and Adolescents With Crohn’s Disease According to 
Race/Ethnicity and Insurance Payor Status
Jennifer L. Dotson, MD, MPH,*,† Michael D. Kappelman, MD, MPH,‡ Josh Bricker, PhD,†  
Rebecca Andridge, PhD,§ Deena J. Chisolm, PhD,† and Wallace V. Crandall, MD, MMM*
Background: Racial and socioeconomic disparities exist in the treatment and outcomes of children and adults with Crohn’s disease (CD). This 
study investigated the impact of race and insurance status on emergency department (ED) evaluation and treatment among children with CD in 
the United States.
Methods: Data from the Pediatric Health Information System included ED visits between January 2007 and December 2013 for patients aged 
≤21 years with a primary diagnosis of CD, or a secondary diagnosis of CD plus a primary CD-related diagnosis. Analyses were performed using 
mixed-effects logistic regression.
Results: Subjects included 2618 unique patients (black,  612 [23%]; white,  2006 [77%]) with 3779 visits from 38 hospitals, a median age of 
14.0 ± 4.0 years, and 50% male. White children had a higher median neighborhood income and were more likely to have private insurance (57% vs 
30%; P < 0.001). Emergency department visits for privately insured patients had higher odds of complete blood count (odds ratio [OR], 1.43; 95% 
CI, 1.08–1.90) and C-reactive protein/erythrocyte sedimentation rate (OR, 1.39; 95% CI, 1.06–1.82) vs Medicaid insured. Visits for white children 
had higher odds of receiving antiemetics (OR, 1.52; 95% CI, 1.06–2.17) vs black children. The proportion of patients with repeat visits was greater 
for black children (33%) than white children (22%; P < 0.001) and greater for Medicaid-insured (27%) than privately insured patients (21%; P < 0.01).
Conclusions: This cross-sectional database study demonstrated that black children and those with Medicaid insurance made more ED visits and 
received somewhat fewer treatments, which may be explained by greater use of the ED for routine care. An opportunity exists for better outpatient 
management of children with IBD so that nonemergent problems are more effectively handled.
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INTRODUCTION
Racial, ethnic, and socioeconomic disparities have been 
reported for treatment and outcomes of  children and adults 
with Crohn’s disease (CD),1–5 a chronic inflammatory bowel 
disease (IBD) affecting more than 600,000 adults and chil-
dren in the United States and Canada alone.6 According to 
the Institute of  Medicine, disparities refer to differences in 
treatment or access that are not due to differences in patient 
health status or preference.7 Recent public policy initiatives 
to improve national health care agree that identifying and 
reducing health-related disparities are essential steps toward 
that goal.8
An especially important area in which to identify poten-
tial health care disparities is the emergency department (ED), 
where multiple diagnostic and treatment decisions are made 
under stressful conditions.7 Under stress and in the absence 
of  standard protocols, human decision-making tends to rely 
upon cognitive biases such as use of  the most recent or most 
available information or most similar past examples,9, 10 As 
such, one might expect disparities in diagnosis and treatment 
to be more apparent in the ED compared with other health 
care settings.
The populations under study for disparate treatment 
are also those who use the ED more frequently. Black, Native 
American, and Hispanic children are significantly more at 
risk for recurrent ED visits and high-frequency utilization of 
EDs.11 Patients with Medicaid coverage, low socioeconomic 
status, and chronic diseases have also been found to utilize ED 
services more frequently.12, 13 There have been similar findings 
in the IBD population for both adults4 and children.2
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 Potential disparities in treatment in the ED have been 
found among adult and pediatric patients. For example, in a 
recent National Center for Health Statistics report on emer-
gency care in the United States from 2008 to 2010, the mean 
ED wait time to see a physician for non-Hispanic blacks was 18 
minutes longer than for non-Hispanic whites.14 A 1-year retro-
spective, case–cohort study of discharged patients from 2 urban 
pediatric EDs found that black children were 39% less likely 
than non-Hispanic white children to receive any analgesic when 
presenting to an ED with abdominal pain, and 68% more likely 
to have a longer length of stay (LOS).15 In a large retrospective 
review of urban pediatric EDs, laboratory testing was ordered 
almost 40% less often, and radiological testing 20% less often, 
for black than for white children.16
As expected, most studies of IBD patients in the ED have 
focused on adults. A systematic review of studies looking at racial 
differences in IBD treatment in the ED found no medication dif-
ferences by race; however, most of these were single- or multicenter 
and, on average, had fewer than 100 subjects.17 In a retrospective 
review of medical records at a single tertiary care center, black chil-
dren with IBD were significantly more likely than white children to 
have a complicated disease course and be treated with corticoste-
roids and infliximab.3 The generalizability of this result is limited 
by the span of time covered, and the single location and small sam-
ple size. It also lacks any measure of family socioeconomic status 
(SES) to potentially account for identified differences.
At this early stage of the literature, it is difficult to assess 
to what extent racial and economic disparities exist for the diag-
nosis and treatment of pediatric IBD patients in the ED. To our 
knowledge, there are no large, nationally representative studies. 
To address this gap in the literature, our study aimed to deter-
mine the impact of race and insurance status on ED evaluation 
and treatment among children and adolescents with CD from a 
large, national administrative database.
Our primary aims were to compare ED medication 
usage, laboratory and radiological testing, and ED disposition 
according to race and insurance status. Secondary aims were to 
determine whether there are race or payor differences in the pro-
portion of patients with repeated visits. Compared with black 
children, we hypothesized that white children would (1) receive 
significantly more laboratory and radiologic testing, (2) receive 
more narcotic pain medications, and (3) have more hospital 
admissions. We also expected to see a similar trend for those 
with commercial insurance compared with Medicaid. Finally, 
the proportion of patients with repeat visits was expected to be 
greater among black children and those with Medicaid insur-
ance than white and commercially insured children, respectively.
METHODS
Data Source
The data for this study were drawn from the Pediatric 
Health Information System (PHIS), an administrative database 
containing inpatient, ED, observation, and ambulatory sur-
gery data from 44 not-for-profit tertiary care pediatric hospi-
tals associated with the Children’s Hospital Association (CHA; 
Overland Park, KS, USA). The PHIS hospitals are among 
the largest children’s hospitals in America. Data in PHIS are 
de-identified upon submission to CHA, but identification num-
bers allow a patient to be tracked across multiple visits within 
the same hospital. Both CHA and the individual sites perform 
data quality and reliability checks (eg, bimonthly coding con-
sensus meetings, coding consistency reviews, and quarterly data 
quality reports across hospitals) before data are included in the 
database. This study included data from 38 hospitals, and the 
total number of hospitals contributing data for a given year 
varied between 31 and 38.
Study Design
This was a retrospective, multicenter, cross-sectional 
study of pediatric CD patients who had at least 1 ED visit at a 
participating PHIS center during the study period.
Study Cohort and Visit Criteria
The unit of analysis for our primary objectives was the 
ED visit. We examined data for all visits within a 7-year time 
window (between January 1, 2007, and December 31, 2013) that 
met the following inclusion criteria: Visits must have been for 
patients who were ≤21 years old and presented to the ED with 
either a primary diagnosis of CD (ICD-9 code: 555.x) or a sec-
ondary diagnosis of CD plus a primary CD-related diagnosis. 
Crohn’s disease–related diagnoses (eg, abdominal pain, ane-
mia, extraintestinal manifestations) were determined by author 
consensus (J.D., W.C., and M.K.) based on a table listing all 
primary diagnoses among visits with a secondary diagnosis of 
CD. Generally, the standards of care related to medications
and testing studied were consistent across the study period.
Additionally, visits must have been for patients who consist-
ently reported being non-Hispanic and either white or black. To 
maintain strictly defined comparison groups, visits for patients
were excluded if  race was missing or inconsistently reported, or
if  patients reported multiracial heritage. As the main analysis is
visit-based, payor status could fluctuate for a given individual.
Variables
Demographics were recorded as follows: age, sex, race, 
ethnicity, hospital location, date of  ED visit, date of  dis-
charge, insurance payor status, encrypted ZIP code, discharge 
ID, primary and secondary discharge diagnoses, and median 
neighborhood income. Median neighborhood income was 
derived by the PHIS data analytics team and was based on 
the 2010 US Census data referring to actual patient ZIP codes 
reported at index hospitalization. As PHIS hospitals transi-
tioned to a new reporting format for race and payor status 
at different times between 2007 and 2009, coding algorithms 
were used to convert old and new versions of  these variables 
into a form that accurately reflects information from both 
versions. Insurance payor status was coded as Medicaid or 
private insurance (Appendix A), and race was coded as black 
or white.
Additional variables included the following: medications 
administered (eg, corticosteroids, antibiotics, pain medications, 
anti-emetics, and “other,” indicating all other medications 
that do not belong to 1 of the aforementioned categories), 
ED disposition (eg, admitted to inpatient status, discharged, 
transferred), laboratory testing (eg, chemistries, immunology), 
imaging studies (eg, magnetic resonance imaging [MRI], ultra-
sound, computed tomography [CT], x-rays), and number of 
visits within the study time frame.
Outcomes
The primary outcomes were medication usage, laboratory 
and radiological testing, and patient disposition. The second-
ary outcome was the number of ED visits per unique patient. 
Primary outcomes were compared in terms of race (non-His-
panic black vs non-Hispanic white) and insurance payor status 
(private vs Medicaid).
Statistical Analyses
Demographic characteristics were compared between 
white and black patients using patient-level data. Pearson chi-
square tests were used for categorical characteristics (sex, geo-
graphic region, insurance payor status, and income quartile) 
and to compare the proportion of repeat vs nonrepeat ED vis-
its by race and by payor status. A 2-sample t test was used for 
age at first visit during the study period, and a nonparametric 
Kruskal-Wallis rank-sum test was used for the number of ED 
visits per patient.
Mixed-level logistic regression modeling was used to 
investigate associations between the predictors (race and 
payor status, in separate models) and primary visit-level out-
comes (medication usage, radiological and laboratory testing, 
and disposition). Fixed effects included race (and/or payor 
status), and random effects included subject and hospital. The 
subject-specific intercept controls for within-subject correla-
tion (eg, patients with multiple visits), and hospital location 
controls for site-specific effects (eg, treatment protocols that 
may differ by hospital; racial diversity of  the local patient 
population). In addition, for outcomes where there was a sta-
tistically significant fixed effect for race or for payor status, 
a bivariate model with both race and payor status was used 
to determine whether each effect remained significant after 
controlling for the other fixed effect. In post hoc analyses for 
significant unadjusted effects of  race or payor status, an inter-
action model was tested using race, payor status, and their 
interaction. To look for stratification of  race by payor status, 
this was followed by a model with a single fixed effect for race, 
which was run with (a) Medicaid only visits and then (b) com-
mercial only visits.
Models were fit using the glmer command from the lme4 
package,18 v1.1–7, in R 3.0.1.19 Models that failed to converge 
were retested with recommended trouble-shooting techniques18 
such as increasing the number of iterations and employing 
alternative nonlinear optimizing algorithms for estimating the 
variance–covariance matrix of random effects. With continued 
nonconvergence, a simpler model was chosen, which included 
the fixed effect (of race or payor status) and either (1) the ran-
dom effect for hospital or (2) the random effect for patient—
depending on convergence and the Bayesian Information 
Criterion. So that models would be comparable, the random 
effects component of each bivariate model was the same as that 
for the corresponding single fixed effect model.
A P value of <0.05 was considered statistically signifi-
cant. This study was approved by the Nationwide Children’s 
Hospital Institutional Review Board.
RESULTS
Demographics
The data included in this study resulted from 3779 ED 
visits, representing 2618 patients (23% black, 77% white) with 
an approximately equal sex distribution (Fig. 1). Table 1 sum-
marizes the subject-based demographics according to race/eth-
nicity for each patient. There were several differences between 
the cohorts with respect to geographic region, payor status, 
and median income. Black children were more likely to have 
Medicaid insurance (P < 0.001) and a lower median neighbor-
hood income (P < 0.001).
Medication Usage
Emergency department visits for white children with CD 
had a higher odds of receiving any medication (OR, 1.50; 95% 
CI, 1.15–1.96), anti-emetics (OR,  1.72; 95% CI, 1.26–2.34), 
and other drugs (OR, 1.67; 95% CI, 1.31–2.14) compared with 
black children. Visits for those who were privately insured had a 
higher odds of receiving anti-emetics (OR, 1.43; 95% CI, 1.05–
1.93) and other drugs (OR, 1.42; 95% CI, 1.10–1.84) compared 
with those who were Medicaid insured (Table 2). When control-
ling for payor status, the odds ratios related to race declined. 
The odds ratio for any drug became only marginally significant 
(OR,  1.36; 95% CI, 1.00–1.86), whereas the odds ratios for 
other drugs (OR, 1.50; 95% CI, 1.12–2.01) and for anti-emetics 
(OR, 1.52; 95% CI, 1.06–2.17) remained significant. When con-
trolling for race, odds ratios relating to payor effects were no 
longer significant.
Laboratory Evaluation
Emergency department visits for white children had a 
higher odds of having any laboratory test (OR, 1.57; 95% CI, 
1.17–2.11), a complete blood count (CBC; OR, 1.41; 95% CI, 
1.09–1.81), chemistries (OR,  1.47; 95% CI, 1.14–1.89), and 
C-reative protein (CRP)/erythrocyte sedimentation rate (ESR;
OR, 1.39; 95% CI, 1.08–1.78) as part of the evaluation com-
pared with black children. Similarly, visits for those who were 
privately insured had a higher odds of having any laboratory 
test (OR,  1.43; 95% CI, 1.04–1.97), a complete blood count 
(OR,  1.51; 95% CI, 1.16–1.98), chemistries (OR,  1.36; 95% 
CI, 1.05–1.77), and CRP/ESR (OR, 1.47; 95% CI, 1.14–1.89) 
(Table  3). However, after controlling for payor status, odds 
ratios based on race were diminished, and none remained sig-
nificant. When controlling for race, odds ratios based on payor 
status remained significant for CBC (OR, 1.43; 95% CI, 1.08–
1.90) and for CRP/ESR (OR, 1.39; 95% CI, 1.06–1.82).
Radiologic Imaging
Emergency department visits for white children had a 
higher odds of having any imaging (OR, 1.44; 95% CI, 1.15–
1.80) and a CT scan (OR, 2.12; 95% CI, 1.36–3.31) compared 
with black children. Visits for those with private insurance had 
a higher odds of receiving any radiologic imaging (OR, 1.35; 
95% CI, 1.08–1.70), x-ray (OR, 1.29; 95% CI, 1.02–1.63), and 
CT scan (OR, 1.67; 95% CI, 1.06–2.61) compared with those 
with Medicaid insurance (Table 3). For each imaging outcome, 
the odds ratio for race was diminished and became nonsignifi-
cant after controlling for payor status and race.
ED Repeat Visit Frequency and Disposition
When evaluating a cohort of patients with more than 
1 ED visit within the 7-year study period, there was a higher 
proportion of black children (33% vs 22%; P  <  0.001) and 
those with Medicaid insurance (27% vs 21%; P < 0.01) com-
pared with white children and private insurance, respectively 
(Table 4).There were no apparent differences by race or payor 
status in the percentage of visits where patients were admitted, 
discharged, or transferred following ED visits. Of note, visits 
involving private insurance were less likely than those involving 
Medicaid to have missing disposition data (OR, 0.34; 95% CI, 
0.17–0.66).
Post Hoc Analyses
In post hoc analysis of the significant unadjusted out-
comes in Tables  2 and 3, there was a significant interaction 
between race and payor status for 4 separate laboratory out-
comes (any lab, CBC, chemistries, and CRP/ESR). To explore 
the nature of these interactions, we evaluated the effects of race 
stratified by payor status. For each lab outcome, there was a 
small effect of race in the Medicaid population and no effect of 
race in the commercial payor population. (Table 5)
DISCUSSION
In a comprehensive evaluation of pediatric IBD patients 
who use the ED, adjusted analyses (with minor exceptions) 
found no significant racial or insurance-related differences 
in the use of imaging, laboratory testing, and medications. 
Contrary to expectations, white children were no more likely 
to receive narcotic analgesics. By contrast, in a large, nation-
ally representative sample of pediatric patients in the ED with 
abdominal pain, Johnson et al.15 found small- to medium-sized 
effects, with whites being 1.6 times more likely than blacks to 
receive any analgesic and 2.6 times more likely to receive a nar-
cotic analgesic. A  key difference may be that the prior study 
included subjects whose primary complaint was abdominal 
Figure 1. Flowchart for the final cohort selection and exclusion criteria. After applying exclusion criteria to the initial database sample of patients 
with Crohn’s disease age ≤21 years with an ED visit between 2007 and 2013, and subsequently applying race/ethnicity exclusions, the final study 
cohort was determined. Abbreviation: GI, gastrointestinal.
pain, cramps, or spasms, whereas abdominal pain was only 1 
of several secondary CD-related diagnoses in the present study. 
The present study may also have been underpowered to identify 
analgesic treatment differences by race.
In adjusted analyses, white children were just as likely 
to receive any imaging overall, and those with private insur-
ance, compared with public insurance, were as likely to receive 
any imaging, and x-ray and CT scans. By contrast, a previous 
study found that white patients were more likely than English-
speaking black patients to receive any imaging (adjusted 
OR,  1.18; 95% CI, 1.05–1.32).16 Although the present study 
looked at all visits, the prior study restricted its focus to patient 
diagnoses with a greater likelihood for imaging services (ie, 
asthma, fever, or acute respiratory tract infection).
The finding that black patients and those with Medicaid 
had more repeat visits to the ED within the study period could 
indicate greater use of the ED for more routine, less urgent care 
and receiving fewer services, although this is speculative with-
out definitive information on disease severity at presentation. 
Previous studies have found that those with Medicaid are 
more likely than those with private insurance to use the ED 
for routine care,20, 21 and this may be due to a variety of factors 
including convenience (ie, scheduling and proximity) and lack 
of copays.22, 23
Patient cost-sharing24, 25 and education have been pro-
posed as potential solutions to better manage outpatient and 
emergency care. Copays are effectively used by private insurers 
to control costs and disincentivize the use of the ED for nonur-
gent care.24, 25 For example, prior literature consistently finds 
that copayments reduce the use of medications,26 with lower-in-
come patients being more sensitive to cost. For ED visits, Selby 
et  al.27 found a greater reduction among low-SES neighbor-
hoods (22.5%) compared with all other neighborhoods (14.6%) 
after the introduction of moderate copays of $25–$30 in a large 
HMO. Slightly larger reductions in ED visits (26%) were found 
with more substantial copayments of $50–$100; however, these 
results were not stratified by visit severity.28 Those with low 
income and/or chronic conditions may be especially vulnerable 







No. (%) P 
Total 2618 612 (23) 2006 (77)
Male 1312 (50) 297 (49) 1015 (51) >0.99
Age-1st visit, mean (SD), y 13.97 (4.00) 13.86 (4.30) 14.00 (3.90) >0.99
Regiona <0.001
 Midwest 891 (34) 211 (34) 680 (34)
 Northeast 559 (21) 95 (16) 464 (23)
 South 877 (33) 271 (44) 606 (30)
 West 291 (11) 35 (6) 256 (13)
Payorb <0.001
 Private 1331 (51) 186 (30) 1145 (57)
 Medicaid 612 (23) 261 (43) 351 (17)
 Other 374 (14) 100 (16) 274 (14)
 Missing 301 (11) 65 (11) 236 (12)
Median incomec <0.001
Q1: $11,130–$35,562 493 (23)  196 (42)  297 (17)
Q2: $35,564–$45,666 534 (24)  117 (25)  417 (24)
Q3: $45,730–$59,671 581 (27)  81 (17)  500 (29)
Q4: $59,718–$148,263 577 (26)  69 (15)  433 (30)
All percentages are by column. Subjects are counted by index visit. Bolded P values represent significant findings.
Abbreviation: NH, non-Hispanic.
aMidwest (OH, IL, MI, IN, MO, WI, MN, NE, ND, SD, KS, IA); Northeast (ME, NH, VT, NY, MA, CT, RI, PA, NJ); South (DC, MD, VA, DE, WV, KY, TN, NC, SC, GA, 
AL, MS, FL, LA, TX, AR, OK); West (AZ, CO, CA, WA, OR, MT, WY, ID, NV, UT, NM, HI, AK).
bCommercial = Blue Cross, HMO, TRICARE, commercial HMO, commercial PPO, commercial other; Medicaid = Medicaid, in-state Medicaid (managed care), in-state Medicaid 
(other), out-of-state Medicaid (all); Other = Medicare, Title V, other government, workers compensation, other insurance company, self-pay, no charge, other payor, charity, hos-
pital chose not to bill; Missing = not recorded, invalid code, unknown.
cMedian of median neighborhood income based on 2010 US Census data compared with ZIP code reported at index hospitalization. Patients (n = 433) and visits (n = 1336) 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































to “cost-offset” effects. Incentivizing patients to delay care until 
their condition is more severe could lead to more expensive 
care for the same episode, though this may not be true for child 
visits.29
Parent medical knowledge may be unreliable to deter-
mine the appropriate use of the ED30; however, interventions 
involving patient or parent education can be effective. Sturm 
et al.23 encouraged families with children to use their primary 
care physicians for less urgent episodes over a 12-month period 
through a program that developed medical decision guidelines 
for afterhours care, outlined primary care provider services and 
availability, and sometimes included access to physician advice 
after hours by phone. In this study, 12% fewer families in the 
intervention used ED services for nonurgent episodes com-
pared with controls.
There were several important limitations in this study. 
One of the biggest limitations is the lack of detailed informa-
tion regarding the characteristics of the source population from 
which patients were drawn at each hospital location. Thus, we 
cannot determine how many people of each race and payor 
TABLE 5: Post Hoc Interaction and Stratified Models for Significant Outcomes
Interaction Model, OR (95 % CI)a
Race Payor Race × Payor
Any lab 1.82 (1.11–2.98) 2.29 (1.25–4.22) 0.45 (0.22–0.93)
CBC 1.76 (1.15–2.68) 2.51 (1.49–4.25) 0.44 (0.24–0.82)
Chemistries 2.07 (1.36–3.17) 2.52 (1.51–4.20) 0.37 (0.20–0.67)
CRP/ESR 1.84 (1.22–2.78) 2.59 (1.57–4.28) 0.41 (0.23–0.74)
Race stratified by payor statusb
Race OR (95% CI)
Medicaid only Commercial only
Any lab 1.79 (1.05–3.05) 0.81 (0.46–1.42)
CBC 1.77 (1.14–2.74) 0.78 (0.49–1.25)
Chemistries 2.02 (1.31–3.10) 0.75 (0.47–1.19)
CRP/ESR 1.80 (1.19–2.73) 0.74 (0.47–1.15)
Significant odds ratios listed in bold.
aThe interaction model for each outcome includes race, payor status, and race × payor status fixed effects plus hospital and patient medical record number as random effects.
bFor each outcome, the model included the fixed effect of race (reference = black) plus hospital and patient medical record number as random effects. This model was run sepa-
rately for visits with Medicaid and commercial payor status.
TABLE 4: Emergency Department Visits According to Patient Race/Ethnicity and Payor Status Over the 7-Year Study 
Period
Patients by Race/Ethnicity Patients by Payor Status
Total NHa Black NH White P Private Medicaid P 
Total No. visits 3779 1036 2743 — 1857 998 —
Total No. patients 2618 612 2006 — 1392 661 —
Visits/patient, median (IQR) 1 (1–1) 1 (1–1) 1 (1–1) >0.99 1 (1–1) 1 (1–2) >0.99
Patients = 1 visit, No. (%) 1983 (76) 411 (67) 1572 (78) 1101 (79) 485 (73)
a,cPatients >1 visit, No. (%) 635 (24) 201 (33) 434 (22) <0.001 291 (21) 176 (27) <0.01
b,cPatients >3 visits, No. (%) 105 (5) 39 (9) 66 (4) <0.001 38 (3) 31 (6) <0.05
Bolded P values represent significant findings.
Abbrevation: NH, non-Hispanic.
aChi-square comparisons: repeat ED visitor (1 visit vs >1 visit) × (1) race and (2) payor status
bChi-square comparisons: repeat ED visitor (1 visit vs >3 visits) × (1) race and (2) payor status
cPercentages are a function of the number of patients included in the chi-square, which may
or may not sum to the total number of patients.
status had 0 visits to derive an accurate proportion of total vis-
its for each subgroup. Questions regarding which groups use 
the ED more frequently are therefore beyond the scope of the 
current study. We evaluated ED visits within PHIS-associated 
hospitals, and this does not account for differences in outpatient 
management that are not captured by PHIS. Approximately 
8% of ED visits were missing the disposition field. As this dis-
proportionately affected those with Medicaid insurance, results 
for low-frequency dispositions (admitted and transferred vis-
its) may be less reliable. The PHIS database is not weighted for 
extrapolation to national estimates; thus results may not be gen-
eralizable to all pediatric centers. This was a retrospective study 
based on administrative data, so reporting bias or classification 
errors may be present, although there are data quality measures 
in place to minimize errors. As the findings were not based on 
detailed medical record review, we were unable to assess or con-
trol for disease presentation or disease severity. Finally, although 
we have interpreted treatment differences by race as an underuse 
of services among black patients, they might represent overuse 
among white patients. The absence of a clear guideline or refer-
ence point for expected treatment in each case renders it difficult 
to distinguish between these 2 interpretations. The strengths of 
the study include its large, regionally diverse sample population 
of ED visits and the use of an analytical method that appropri-
ately accounted for data clustering by patient and hospital.
In summary, several small31 treatment differences were 
identified separately by race and by insurance payor status in a 
large and diverse cohort of pediatric patients with CD visits to 
the ED. Given the strong overlap between race and insurance 
type with white patients more likely to have private insurance 
and black patients more likely to have Medicaid, it is not sur-
prising that, for several treatment outcomes, racial differences 
were no longer apparent after accounting for payor differences, 
despite expectations based on the literature. To the extent that 
the 2 predictors are correlated, the effective sample size is 
reduced, and it is often difficult to tease out their independent 
effects. Although effect sizes identified in this study were small, 
it is important to minimize such differences as much as possible. 
Interestingly, in the post hoc analyses, white patients were more 
likely to receive any lab testing when using Medicaid but not 
private insurance. It seems that being black and having limited 
access to insurance represents a double risk in terms of access 
to some care. Perhaps white patients were treated the same irre-
spective of insurance. These differences may represent differ-
ences between hospitals (eg, black patients in some urban areas 
may use hospitals with lower rates of evidence-based practices32 
or limited resources).
The root causes of  health care disparities in the United 
States are complex and beyond the scope of this study, which 
is limited to identifying racial and economic disparities. Given 
the limitations of  our data set, we cannot determine whether 
these small apparent differences represent racial disparities in 
the quality of  health care. In general, multiple strategies may 
be necessary to address the inappropriate use of  the ED, espe-
cially among families with lower incomes. Our results suggest 
an opportunity for better outpatient management of  children 
with IBD, particularly among black children and those with 
Medicaid, so that nonemergent problems are more effectively 
handled in the office setting rather than ED. Examples of  inter-
ventions to improve our outpatient management approach 
include extended evening and weekend clinic hours, enhance-
ment and utilization of  electronic patient portals, increasing 
the focus on proactive management of  these patients (eg, use 
of  clinical dashboards to monitor from a population perspec-
tive), providing additional education and resources to our 
patients and families, and fully integrating supportive multi-
disciplinary teams—including case managers, social workers, 
and psychologists—into our practice. Addressing these com-
plex psychosocial issues and social determinants of  health is 
particularly challenging without embedded social workers and 
psychologists. Large, carefully crafted prospective studies with 
a focus on social determinants of  health are needed to address 
these issues.
In addition, future research should focus on how to 
address family concerns about inconvenience surrounding pri-
mary care or specialty outpatient clinics and the effective use of 
copays without discouraging ED services when necessary.
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APPENDIX A: Mapping Key for Each Payor Category According to PHIS Payor Titles from Version 1 and Version 2
PHIS Payor Title
Payor Categories Version 1a Version 2a
Medicaid Medicaid In-state Medicaid (managed care); in-state Medicaid 
(other), out-of-state Medicaid (all)
Commercial HMO, Blue Cross Commercial (HMO, PPO, or other), TRICARE
Other Medicare, other government, self-pay, other insurance company, no 
charge, Title V, workers compensation, other
Medicare, Other government, self-pay, other payor, 
hospital chose not to bill, charity
Missing Not recorded, invalid Not recorded, invalid, unknown
aDuring the study period, PHIS changed its reporting from version 1 to version 2, which affected how payor status was reported. This table depicts the mapping process of each 
version into the 3 categories we used for analysis.
